FDA Grants Fast Track Designation for Ambrxs ARX517 for the Treatment of Metastatic Castration-Resistant Prostate Cancer

AMAMDelisted Stock  USD 15.73  0.71  4.73%   
About 55% of Ambrx Biopharma's investors are presently thinking to get in. The analysis of current outlook of investing in Ambrx Biopharma American suggests that some traders are interested regarding Ambrx Biopharma's prospects. Ambrx Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Ambrx Biopharma American. Many technical investors use Ambrx Biopharma American stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
SAN DIEGO, July 19, 2023 Ambrx Biopharma Inc., Ambrx , today announced that the U.S. Food and Drug Administration has granted Fast Track designation to Ambrxs

Read at benzinga.com
benzinga news
  

Ambrx Biopharma Fundamental Analysis

We analyze Ambrx Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ambrx Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ambrx Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Ambrx Biopharma is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Ambrx Biopharma American Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ambrx Biopharma stock to make a market-neutral strategy. Peer analysis of Ambrx Biopharma could also be used in its relative valuation, which is a method of valuing Ambrx Biopharma by comparing valuation metrics with similar companies.

Peers

Ambrx Biopharma Related Equities

XFORX4 Pharmaceuticals   11.43   
0%
100.0%
IMMXImmix Biopharma   7.11   
0%
62.0%
HEPAHepion Pharmaceuticals   4.69   
0%
41.0%
ELEVElevation Oncology   3.23   
0%
28.0%
ENVBEnveric Biosciences   3.13   
0%
27.0%
ZURAZura Bio   1.67   
0%
14.0%
DAWNDay One   1.53   
0%
13.0%
ABOSAcumen Pharmaceuticals   0.44   
0%
3.0%
INZYInozyme Pharma   0.37   
3.0%
0%
OCEAOcean Biomedical   1.41   
12.0%
0%
SONNSonnet Biotherapeutics   2.28   
19.0%
0%
CNSPCns Pharmaceuticals   8.33   
72.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Ambrx Stock

If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas